PRNewswire (Thu, 6-Aug 12:00 PM ET)
Business Wire (Thu, 6-Aug 10:17 AM ET)
PRNewswire (Thu, 6-Aug 10:07 AM ET)
TipRanks (Wed, 5-Aug 1:30 PM ET)
PRNewswire (Wed, 5-Aug 10:07 AM ET)
Business Wire (Tue, 4-Aug 2:49 PM ET)
Globe Newswire (Wed, 15-Jul 8:30 AM ET)
iTonic Holdings Secures 180-Day Nasdaq Extension—Critical Countdown to Maintain Listing Begins
Market Chameleon (Fri, 24-Apr 7:44 AM ET)
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
Itonic Holdings - Class A trades on the NASDAQ stock market under the symbol ITOC.
As of August 6, 2026, ITOC stock price was flat at $0.29 with 23,402 million shares trading.
ITOC has a beta of -0.54, meaning it tends to be less sensitive to market movements. ITOC has a correlation of 0.01 to the broad based SPY ETF.
ITOC has a market cap of $4.94 million. This is considered a Sub-Micro Cap stock.
ITOC support price is $.27 and resistance is $.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ITOC shares will trade within this expected range on the day.
